Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis

被引：0
|
作者：
Radojka M. Savic
Ana M. Novakovic
Marianne Ekblom
Alain Munafo
Mats O. Karlsson
机构：
[1] University of California San Francisco,Department of Bioengineering and Therapeutic Sciences
[2] Uppsala University,Department of Pharmaceutical Biosciences
[3] Persson Ekblom Sarl,undefined
[4] Merck Institute for Pharmacometrics,undefined
来源：
Clinical Pharmacokinetics | 2017年 / 56卷
关键词：
Multiple Sclerosis; Cladribine; Visual Predictive Check; Oral Tablet; Absorption Delay;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1245 / 1253
页数：8
相关论文
共 50 条
  • [1] Population Pharmacokinetics of Cladribine in Patients with Multiple Sclerosis
    Savic, Radojka M.
    Novakovic, Ana M.
    Ekblom, Marianne
    Munafo, Alain
    Karlsson, Mats O.
    CLINICAL PHARMACOKINETICS, 2017, 56 (10) : 1245 - 1253
  • [2] Pharmacokinetics of oral cladribine (Mylinax®) after administration in patients with multiple sclerosis
    Munafo, A
    Tran, D
    Marcus, S
    MULTIPLE SCLEROSIS, 2005, 11 : S173 - S173
  • [3] Pharmacokinetics of oral cladribine (Mylinax®) after administration in patients with multiple sclerosis
    Munafo, A
    Tran, D
    Marcus, S
    Ammoury, N
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 238 : S225 - S225
  • [4] Population Pharmacokinetics and Target Engagement of Natalizumab in Patients With Multiple Sclerosis
    Muralidharan, Kumar Kandadi
    Kuesters, Geoffrey
    Plavina, Tatiana
    Subramanyam, Meena
    Mikol, Daniel D.
    Gopal, Sreeja
    Nestorov, Ivan
    JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 57 (08): : 1017 - 1030
  • [5] CANCER RISK IN MULTIPLE SCLEROSIS PATIENTS TAKING CLADRIBINE
    Pakpoor, Julia
    Disanto, Giulio
    Altmann, Daniel R.
    Pavitt, Sue
    Turner, Benjamin
    Calado-Marta, Monica
    Juliusson, Gunnar
    Baker, David
    Chataway, Jeremy
    Schmierer, Klaus
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2014, 85 (10):
  • [6] Safety and Efficacy of Intravenous Cladribine in Multiple Sclerosis Patients
    Alchaki, Abdul Rahman
    Anadani, Nidhiben
    Cook, Stuart
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 28 - 29
  • [7] Cladribine (Mavenclad) for Multiple Sclerosis
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2019, 61 (1577): : 118 - 120
  • [8] Oral cladribine for multiple sclerosis
    Ellison, GW
    Myers, LW
    NEUROLOGY, 1997, 48 (03) : 3070 - 3070
  • [9] TREATING MULTIPLE SCLEROSIS WITH CLADRIBINE
    Alvarez-Gonzalez, C.
    Allen-Philbey, K.
    Mathews, J.
    Turner, B. P.
    Baker, D.
    Gnanapavan, S.
    Marta, M.
    Giovannoni, G.
    Schmiere, K.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (12):
  • [10] Cladribine hope for multiple sclerosis
    Kirsty Minton
    Nature Reviews Immunology, 2009, 9 : 387 - 387
12345